ARCT vs FAST · rev $152.3M vs P/E 43, rev $7.55B
Arcturus Therapeutics Holdings Inc (ARCT) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported ARCT revenue for 2024-12-31 was $152.3M. Net income was -$80.9M. Revenue was down 8.7% from 2023-12-31 to 2024-12-31. ARCT currently screens at market cap $369.4M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
ARCT currently screens at market cap $369.4M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the ARCT and FAST stock pages for the full models.
Not investment advice.